AngioDynamics (ANGO) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today -1

2 insiders sold $655K. No buys.

SellStephen A. Trowbridge$290KEVP and CFOat $12.27 on Oct 29, filed Oct 30

SellStephen A. TrowbridgeEVP and CFO$290Kat $12.27 on Oct 29, filed Oct 30

SellStephen A. Trowbridge$21KEVP and CFOat $12.17 on Oct 28, filed Oct 30

SellStephen A. TrowbridgeEVP and CFO$21Kat $12.17 on Oct 28, filed Oct 30

SellWarren Nighan Jr.$344KSVP Quality and Regulatoryat $14.72 on Jul 30, filed Jul 31

SellWarren Nighan Jr.SVP Quality and Regulatory$344Kat $14.72 on Jul 30, filed Jul 31

From SEC Form 4s, the newest filed Oct 30, 2026 · Insiders have 2 business days to file a trade

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 3 tradesSee it live, free for 24 hours. No account. No card. Then keep going with a free account.

Pro members see every filing on ANGO with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at AngioDynamics

Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about ANGO's insider trades

As of Nov 4, 2026: AngioDynamics (ANGO) has 3 insider filings on record in the last 6 months, the newest filed Oct 30, 2026. Its Quality Score is -1 (Poor). Scores as of 10:55 AM ET, 15 minutes behind.

Are ANGO insiders buying or selling?

2 insiders sold $655K across 3 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Stephen A. Trowbridge, EVP and CFO, sold $290K on Oct 29, 2026.

Who are ANGO's biggest insider sellers?

By the dollars of their sales in the last 6 months: Warren Nighan Jr. (SVP Quality and Regulatory), 1 sale; Stephen A. Trowbridge (EVP and CFO), 2 sales.

When did an ANGO insider last buy?

No ANGO insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Stephen A. Trowbridge on Oct 29, 2026.

AngioDynamics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Medical Devices.